Estracyt, new therapeutic agent for cancer of the prostate
Bouffioux, C.; de Leval, J.
Revue Medicale de Liege 35(24): 865-870
1980
ISSN/ISBN: 0370-629X PMID: 7209203 Document Number: 166441
Document emailed within 1 workday
Related Documents
Yamanaka, H.; Shida, K. 1984: Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt" Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 537-544Yamanaka, H.; Shimazaki, J.; Imai, K.; Sugiyama, Y.; Shida, K. 1977: Effect of estracyt on the rat prostate Investigative Urology 14(5): 400-404
Roth, B.J. 1996: New therapeutic agents for hormone-refractory prostate cancer Seminars in Oncology 23(6 Suppl 14: 49-55
Jönsson, G. 1971: Continued experiences with Estracyt in the treatment of advanced prostatic cancer Nordisk Medicin 85(6): 186-187
Hata, M. 1988: Stage D1 prostatic cancer benefited by a single regimen of Estracyt Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(5): 1787-1790
Cellini, N.; Luzi, S.; Morganit, A.G.; Smaniotto, D.; Mattiucci, G.C.; Digesù, C.; Mangiacotti, M.G.; Cellini, F.; Valentini, V. 2002: Biological factors and therapeutic modulation in prostate cancer radiotherapy Rays 27(3): 205-214
Khauli, R.B. 2005: Prostate cancer: diagnostic and therapeutic strategies with emphasis on the role of PSA Le Journal Medical Libanais. Lebanese Medical Journal 53(2): 95-102
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Forshell, G.P.; Müntzing, J.; Ek, A.; Lindstedt, E.; Dencker, H. 1976: The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer Investigative Urology 14(2): 128-131
Bishr, M.; Lattouf, J.B.; Gannon, P.O.; Saad, F. 2011: Updates on therapeutic targets and agents in castration-resistant prostate cancer Minerva Urologica e Nefrologica 63(2): 131-143
Hu, Y.-H.; Guo, J.-C.; Zhang, M. 2017: Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(12): 1138-1140
Peneau, M.; Piéchaud, T.; Cariou, G.; Ragni, E.; Fontaine, E.; Fournier, G. 1998: Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 977-993
Petrylak, D.P. 2011: Evolving therapeutic paradigms for advanced prostate cancer: what's needed to make optimal use of the new treatments Oncology 25(6): 514-515
Jackson, K.M.; Frazier, M.C.; Harris, W.B. 2007: Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer Anticancer Research 27(3b): 1483-1488
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Honda, T.; Gjertsen, B.T.; Spurgers, K.B.; Briones, F.; Lee, S.J.; Hobbs, M.L.; Meyn, R.E.; Roth, J.A.; Logothetis, C.; McDonnell, T.J. 2001: Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction Anticancer Research 21(5): 3141-3146
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654